DIAMAS
Contact DIAMAS
Location: 1102 Palo Verde Rd, Irvine, California 92617, United States United States
Founded in: 2008
Stage: Alpha (prototype)
Number of employees: 1-5
Profitable year: 2010
Short URL: vator.co/diamas
Admins (1)
Followers (156)
 
 
 
 
 
 
 
 
 

DIAMAS

Diamonds are a surgeon’s best friend
Startup/business
California, United States United States United States
http://webfiles.uci.edu/gbisht/Diamas
Follow
 156
Recommend
About
Video/documents
Company description
Diamond coatings remain the optimal choice for strength and sharpness for precision surgical instruments; however their high costs prevent wide adoption in the healthcare industry today.  DIAMAS’ innovative diamond nano-composite technology provides the solution, offering the strength of diamond with ultra- fine features at a fraction of the cost. DIAMAS offers an unprecedented value proposition with strong intellectual property placing it among the top contestants in the competitive landscape.
DIAMAS targets a total market size of $4.57B in the United States by partnering with top surgical instrument manufacturers. DIAMAS will operate through off-site and in-factory coating services for licensing and operational fees. Financial projections estimate a revenue generation of $1.8 M by end of first year expected to rise to $10M by year 5 with a total startup cost of $750K. DIAMAS will achieve this goal through a management team with year of technological expertise, medical exposure and business experience
Team

Mr. Gobind Bisht is the acting CEO and brings management and business experience along with knowledge of intellectual property protection. He holds a Technology Degree in Biotechnology from Indian Institute of Technology, Kharagour and currently MS candidate at UC Irvine.  He has extensive business and technological experience as a founding researcher of DLN technology and a serial entrepreneur. He has been  the founding member and business advisor to key events organized by IIT.

 

  Mr. Robert Gorkin is the acting VP R&D and brings research experience from pharma gaint Merck & Co. and BioMEMS lab at UC Irvine. He holds a technology degree from University of Pittsburgh in Biomedical Engineering and currently a PhD candidate at UC Irvine. He expertises in consulting for technology startups while working with SubQ (Glucose sensing), Phasiks (On-chip diagnostics) and GenePOC (Sample-to-answer influenza detection).

 

 

Business model
DIAMAS' direct customers are surgical instrument distributers/manufacturers that provide hospitals and specialty clinics with various tools for surgeries.  DIAMAS will work towards strategic alliances with the major distributors to target addressable segments of the surgical instrumentation market. DIAMAS will start operations with mainstream revenues coming from coating fees including: coating costs, royalties and premiums.  This will gradually transition into partnerships requiring coating services at customers’ facilities bringing revenues from lease, operations and maintenance of coating equipment.
Competitive advantage
DIAMAS offers diamond film coating services based on a patent-pending Diamond-like Nanocomposite (DLN) technology.  Specifically, we envision this technology applied to specialty surgical instruments.  DIAMAS films are unique because they can provide the sharpest cutting edges on the market with diamond-like hardness and atomic scale surface smoothness. DIAMAS is favourably positioned in the technology landscape offering most value for reasonable prices. DIAMAS' value proposition is the sharpest cutting technology at most affordable prices and hold a vision towards creating the highest standards without the highest prices